Navigation Links
Study Finds No Link Between Statins And Breast Cancer Risk

A new study has found that there is no link whatsoever between breast cancer and cholesterol levels and the use of statins or lipid lowering drugs //to control the same.

The details of the study are available in the October 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article says that although some evidence has been uncovered in previous studies to suggest that the statins may work in conjunction with other chemotherapy drugs in breast cancer, studies that specifically tried to link up the two have given out mixed results. In the current study, data from the Nurses' Health Study was used to check for any association of breast cancer with statins and high levels of cholesterol. A. Heather Eliassen, Sc.D., of the Brigham and Women's Hospital, Boston, Mass., and colleagues tracked 79,994 women through questionnaires completed in 1988, 1994, 1996, 1998 and 2000. Breast cancer cases starting from 1988 to May, 2000 were also followed up. It was found that there were 3,177 cases on invasive breast cancer including 1,727 among statin users. "In summary, the results of this study suggest that the beneficial effect of statins on breast cancer observed in experimental studies may not be applicable to humans. We also found no associations of general lipid-lowering drugs and serum cholesterol levels with breast cancer risk. Further study is warranted to evaluate the associations of longer durations of statin use and specific types of statins with breast cancer risk," the authors conclude.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer

Post Your Comments:
(Date:11/25/2009)..., SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--...nterforDrugEvaluationandResearch,titled"ADifficult...rsintheNov.26,2009issueofTheNewEnglandJournalofMed.../prnh/20090824/FDALOGO ) ,, Inthearticle,Woodco...topainmedicationforthosewhoneeditandmanagingtheris...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQu...inter Spare the Air Alert forThursda...firelogsoranyothersolidfuel,bothindoorsandoutdoors...yairqualitytomorrow,"saidJackBroadbent,executiveof...torespectthehealthoftheirneighborsandfellowcommuni...
(Date:11/25/2009)...-term survivors of testicular cancer who were trea...ere side effects, including neurological side effe...not treated with chemotherapy, according to a new ... of the National Cancer Institute . , Marianne B...nd University Hospital, in Bergen, Norway, and col...
(Date:11/25/2009)...fortuitous discovery that grew out of a collaborat...tentially offer hope to the nearly 10 million Amer... , Also known as hardening of the arteries, ...irculatory problem in which narrowed arteries redu...dered a red flag for vascular disease, heart attac...
(Date:11/25/2009)...udy follow-up period was too short to draw definit...AY, Nov. 25 (HealthDay News) -- In diabetic patien...o be no difference in outcomes at one year whether...th stenting, British researchers report. , Bypa...betic patients with coronary artery disease. Howev...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...norrhea, one of the most common sexually transmitt...scientists say they are running // out of options ...ibe a group of commonly used antibiotics including...ion (CDC) says that the sexual disorder-that affec...
...rmaphrodites, commonly known as eunuchs, can now c...ive birth to babies - thanks //to a special proced...l Sciences (AIIMS) here. After proper diagnos...ier research and referral institute said. "T...
...Child abuse casts a shadow the length of a lifetim...tter Truth Little Sana was home alone, happ...while her mom eked out a living in a neighborhood .... He locked the door and raped her repeatedly. ...
...th allergy season in full bloom, the American Acad...ffering a reminder of what you can do to cope with...throat specialist can help. // This spring, p...s, nasal congestion and drainage, and sometimes he...
...ti-smoking campaigns highlighting the risk of resp... at women, according to a new study published in t...rofessor Robert Adams of the Queen Elizabeth Hospi...found hospital admissions and mortality from asthm...
...ctors should not shy away from writing letters of ... according to an article in the latest Medical Jou...igious society, some doctors may be wary of pennin... 'Letters can be dangerous in the hands of law...
Other Medicine News:Health News:Scientists Concerned About Gonorrhea’s Drug Resistanc 2Health News:New Procedure Paves Way for Eunuchs to Choose a Gender and Conceive 2Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 2Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 3Health News:April Showers Bring May Flowers – And Plenty of Pollen, To 2
(Date:11/25/2009)...Call/--Hologic,Inc.(HologicortheCompany)(Nasdaq: H...remiumdiagnostics,medicalimagingsystemsandsurgical...n,isusingtheannualmeetingoftheRadiologicalSocietyo...ber29throughDecember3,2009tohighlightournewSecurVi...stationsoftware. ,, TheHologicSecurViewworkstat...
(Date:11/25/2009)...dsResearchGroup,Inc.releasedWave1ofits LaunchTren...yndicatedmarketresearchprojecttrackingthelaunchofC...oughthefirstsixmonthsofavailability.Eachwaveofther...rmatologistsandqualitativeinformationfromasubsetof...ouse,typicalpatienttypes,productperceptions,promot...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 1AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 3AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 4AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 5AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 6AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 7AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 8AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 9AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 10AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 11AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 12AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 13AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 14AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 15AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 16AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 17AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 18AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 1AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 2AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 3First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 1First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 2First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 3
...reported in,the journal Pharmacogenomics suggests ...ic Factor gene (CNTF) may affect response to,antip...Pharmaceuticals,Inc., included patients with acute... with Fiapta(TM) (iloperidone), a novel atypical,a... FDA, or placebo.,Patients were also studied for a...
...r Blood-Derived Stem Cells and Strong In...NEW YORK, Feb. 28 NeoStem, Inc. (Amex: NBS ),whi...ssing and long-term,storage of adult stem cells fo...ositive research conclusions and industry trends p...sociation and at the recent Third Annual,Stem Cell...
Other Medicine Technology:Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 2NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 3NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 4
Frazier
Ferguson-Frazier suction tube # 4
Ferguson-Frazier suction tube # 0
UltraLite® Plus Headlight System
Medicine Products: